Variable | Linezolid group | Control group | P value |
---|---|---|---|
Number | 164 | 172 | Â |
Age, years | 54.6 ± 11.9 | 57.0 ± 14.7 | 0.153 |
Gender, female | 112 (68.3) | 104 (60.5) | 0.134 |
BMI, kg/m2 | 17.4 ± 5.0 | 18.5 ± 5.7 | 0.158 |
NTM-PD, retreatment | 64 (39.0) | 60 (34.9) | 0.432 |
Previous pulmonary TB | 34 (20.7) | 42 (24.4) | 0.419 |
Comorbidity | Â | Â | Â |
COPD | 12 (7.3) | 18 (10.5) | 0.312 |
Diabetes Mellitus | 8 (4.9) | 6 (3.5) | 0.524 |
Immunosuppressed | 6 (3.7) | 9 (5.2) | 0.485 |
Respiratory symptoms | Â | Â | Â |
Cough | 122 (74.4) | 139 (80.8) | 0.158 |
Expectoration | 122 (74.4) | 139 (80.8) | 0.158 |
Hemoptysis | 66 (40.2) | 80 (46.5) | 0.247 |
Fever | 25 (15.2) | 30 (17.4) | 0.586 |
Dyspnea | 24 (14.6) | 27 (15.7) | 0.786 |
Chest CT findings | Â | Â | Â |
Nodular bronchiectatic | 119 (72.6) | 134 (77.9) | 0.256 |
Fibrocavitary | 58 (35.3) | 49 (28.5) | 0.176 |
Other | 6 (3.7) | 8 (4.7) | 0.649 |